PACS IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PACS Group Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action

New York, NY–(Newsfile Corp. – January 1, 2025) – WHY? The Rosen Law Firm, a global investor rights law firm, is reminding purchasers of PACS Group Inc.’s (NYSE: PACS ) (i) common stock pursuant to and/or traceable registration statement and prospectus (collectively, the “Registration Statement”). connection with the Company’s April 11, 2024 initial public offering (“IPO”); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant to and/or traceable to the registration statement and prospectus issued materially in connection with the Company’s September 2024 secondary public offering (“SPO”); January 13, 2025 lead plaintiff deadline.

SO WHAT? If you purchased PACS common stock pursuant to and/or traceable to the IPO and/or securities during the Class Period, you may be entitled to compensation without payment of any cash fees or expenses through a contingency fee arrangement.

WHAT TO DO NEXT? To join the PACS class action, visit https://rosenlegal.com/submit-form/?case_id=30617 or call Philip Kim, Esq. Toll free at 866-767-3653 or by email at case@rosenlegal.com. A class action lawsuit has already been filed. If you want to act as the main plaintiff, you must move to court no later than January 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in leading the litigation.

WHY CHOOSE ROSEN LAW? We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, notifying companies do not have comparable experience, resources or the recognition of any meaningful peers. Many of these firms do not actually handle securities class actions, but are simply brokers who refer clients or partners to law firms that actually handle litigation. Be Wise When Choosing Counsel The Rosen Law Firm represents investors worldwide, focusing its practice in securities class action and shareholder derivative litigation #1 rating by ISS Securities Class Action: (WA:) Services for securities class actions in 2017. The company has been ranked in the top 4 every year since 2013. In 2019 alone, the company secured more than 438 million dollars for investors Founding partner Lawrence Rosen was named a titan of plaintiffs’ counsel by law360.Many of the firm’s attorneys have been recognized By Lawdragon and Super Lawyers.

DETAILS OF THE CASE. According to the lawsuit, in the Registration Statement and during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: More than 100% of PACS operating and net income in 2020-2023. (2) PACS engaged in a “scheme” to “bill Medicare for thousands of unnecessary respiratory and sensory integration therapies”; (3) PACS engaged in a scheme to falsify licensing and personnel documents; and (4) as a result of the above, the defendants’ positive statements about PACS’ business, operations and prospects were materially misleading and/or lacked a reasonable basis.When the true details came to market, the suit alleges, investors suffered damages.

To join the PACS class action, visit https://rosenlegal.com/submit-form/?case_id=30617 or call Philip Kim, Esq. Toll free at 866-767-3653 or by email at case@rosenlegal.com.

No class has been certified. Unless you are represented by an attorney. You may choose to remain a member of the class and do nothing at this time potential future recovery is not dependent on serving as lead plaintiff.

Follow us for updates on LinkedIn at https://www.linkedin.com/company/the-rosen-law-firm , on Twitter at https://twitter.com/rosen_firm or on Facebook ( NASDAQ: ). https:/ /www.facebook.com/rosenlawfirm/.

Advertisement of a lawyer. Past results do not guarantee a similar result.

——————————

To view the original version of this press release, visit https://www.newsfilecorp.com/release/235491